Clinical trial
Does An Abnormal PFA 100 Predict Bleeding After Renal Biopsy?
NCT00334204 · University of Mississippi Medical Center, Other · Terminated
Key facts
| NCT number | NCT00334204 |
|---|---|
| Title | Does An Abnormal PFA 100 Predict Bleeding After Renal Biopsy? |
| Official title | Does An Abnormal PFA 100 Predict Bleeding After Renal Biopsy? |
| Lead sponsor | University of Mississippi Medical Center, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Failure, Acute, Chronic, Blood Platelet Disorders, Hemorrhage |
| Intervention type | Device |
| Interventions | measuring Platelet Function Analyser-100 (PFA-100) platelet function before kidney biopsy |
| Enrollment | 58 |
| Start date | Aug 1, 2004 |
| Primary completion | May 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jun 6, 2006 |
| Last update posted | Aug 1, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: